| Product Code: ETC337604 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Parenteral drugs represent a critical segment of Bahrains pharmaceutical market, covering injectables administered in hospitals and clinical settings. These include antibiotics, vaccines, and biologics. Demand is driven by chronic disease management, surgical needs, and emergency care. Bahrain relies on regulated imports and collaborations with global pharmaceutical manufacturers to ensure a stable supply.
Bahrains parenteral drugs market is growing steadily due to advancements in healthcare infrastructure, increased prevalence of chronic diseases, and rising demand for injectable therapeutics. Hospitals and clinics are increasingly adopting ready-to-use injectable solutions to enhance patient care efficiency. Regulatory support for pharmaceutical manufacturing and rising healthcare spending are further contributing to market development.
The parenteral drugs market in Bahrain is limited by the small patient population and a lack of local pharmaceutical manufacturing infrastructure. Importing sterile injectables involves strict regulatory compliance and high costs, which limit availability and drive up prices. Additionally, cold chain logistics present a challenge in ensuring drug efficacy. Public healthcare coverage is selective, and private sector demand remains constrained due to high treatment costs.
The healthcare sector in Bahrain is witnessing strong government backing, leading to growth in demand for parenteral (injectable) drugs. Investment in local manufacturing facilities for sterile injectables, along with partnerships in pharmaceutical research and distribution, can yield robust returns and support regional healthcare resilience.
Parenteral drugs, including injectable pharmaceuticals, are heavily regulated in Bahrain by the National Health Regulatory Authority (NHRA). The approval process for these drugs involves stringent reviews of sterility, bioavailability, and pharmacokinetic data. Facilities involved in production and importation must hold Good Manufacturing Practice (GMP) certifications, and product recalls are enforced in cases of contamination. The NHRA conducts periodic inspections and audits, ensuring Bahrain aligns with international standards from the FDA and EMA.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Parenteral Drugs Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Parenteral Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Parenteral Drugs Market - Industry Life Cycle |
3.4 Bahrain Parenteral Drugs Market - Porter's Five Forces |
3.5 Bahrain Parenteral Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Bahrain Parenteral Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Bahrain Parenteral Drugs Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.8 Bahrain Parenteral Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Bahrain Parenteral Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahrain Parenteral Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral drug administration |
4.2.2 Growing geriatric population in Bahrain |
4.2.3 Technological advancements in drug delivery systems |
4.2.4 Government initiatives to improve healthcare infrastructure |
4.2.5 Rising demand for specialized parenteral drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of parenteral drugs |
4.3.2 High cost associated with parenteral drug development and production |
4.3.3 Limited availability of skilled healthcare professionals for administering parenteral drugs |
4.3.4 Concerns regarding potential side effects and complications of parenteral drug administration |
4.3.5 Competition from alternative drug delivery methods |
5 Bahrain Parenteral Drugs Market Trends |
6 Bahrain Parenteral Drugs Market, By Types |
6.1 Bahrain Parenteral Drugs Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Parenteral Drugs Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Bahrain Parenteral Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 Bahrain Parenteral Drugs Market Revenues & Volume, By Immunoglobulin, 2021 - 2031F |
6.1.5 Bahrain Parenteral Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.6 Bahrain Parenteral Drugs Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.7 Bahrain Parenteral Drugs Market Revenues & Volume, By Peptide Hormones, 2021 - 2031F |
6.1.8 Bahrain Parenteral Drugs Market Revenues & Volume, By Blood Factors, 2021 - 2031F |
6.1.9 Bahrain Parenteral Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.1.10 Bahrain Parenteral Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Bahrain Parenteral Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Parenteral Drugs Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Bahrain Parenteral Drugs Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.2.4 Bahrain Parenteral Drugs Market Revenues & Volume, By Diabetes, 2021 - 2031F |
6.2.5 Bahrain Parenteral Drugs Market Revenues & Volume, By Blood disorders, 2021 - 2031F |
6.2.6 Bahrain Parenteral Drugs Market Revenues & Volume, By Hormonal Disorders, 2021 - 2031F |
6.2.7 Bahrain Parenteral Drugs Market Revenues & Volume, By Musculoskeletal Disorders, 2021 - 2031F |
6.2.8 Bahrain Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.9 Bahrain Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.3 Bahrain Parenteral Drugs Market, By Molecule Type |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Parenteral Drugs Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.3.3 Bahrain Parenteral Drugs Market Revenues & Volume, By Large Molecules, 2021 - 2031F |
6.4 Bahrain Parenteral Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Parenteral Drugs Market Revenues & Volume, By Intravenous (IV), 2021 - 2031F |
6.4.3 Bahrain Parenteral Drugs Market Revenues & Volume, By Intramuscular (IM), 2021 - 2031F |
6.4.4 Bahrain Parenteral Drugs Market Revenues & Volume, By Subcutaneous (SC), 2021 - 2031F |
6.5 Bahrain Parenteral Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Bahrain Parenteral Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Bahrain Parenteral Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Bahrain Parenteral Drugs Market Revenues & Volume, By Drug Stores, 2021 - 2031F |
6.5.5 Bahrain Parenteral Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Bahrain Parenteral Drugs Market Import-Export Trade Statistics |
7.1 Bahrain Parenteral Drugs Market Export to Major Countries |
7.2 Bahrain Parenteral Drugs Market Imports from Major Countries |
8 Bahrain Parenteral Drugs Market Key Performance Indicators |
8.1 Rate of adoption of advanced drug delivery systems in healthcare facilities |
8.2 Number of clinical trials and research studies focused on parenteral drugs in Bahrain |
8.3 Percentage of healthcare facilities offering specialized parenteral drug administration services |
8.4 Patient satisfaction scores related to the efficacy and safety of parenteral drugs |
8.5 Investment in research and development of new parenteral drug formulations |
9 Bahrain Parenteral Drugs Market - Opportunity Assessment |
9.1 Bahrain Parenteral Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Bahrain Parenteral Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Bahrain Parenteral Drugs Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.4 Bahrain Parenteral Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Bahrain Parenteral Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahrain Parenteral Drugs Market - Competitive Landscape |
10.1 Bahrain Parenteral Drugs Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Parenteral Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here